Compare CSL & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSL | BAX |
|---|---|---|
| Founded | 1917 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 13.9B |
| IPO Year | 1994 | 1994 |
| Metric | CSL | BAX |
|---|---|---|
| Price | $315.87 | $22.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 9 |
| Target Price | ★ $401.67 | $21.00 |
| AVG Volume (30 Days) | 575.9K | ★ 4.8M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.27% | 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.37 | 0.21 |
| Revenue | $5,003,600,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $2.59 | $1.96 |
| Revenue Next Year | $4.50 | $2.22 |
| P/E Ratio | ★ $34.19 | $109.62 |
| Revenue Growth | ★ 9.08 | 5.72 |
| 52 Week Low | $293.43 | $15.73 |
| 52 Week High | $432.91 | $30.00 |
| Indicator | CSL | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 30.37 |
| Support Level | N/A | $21.28 |
| Resistance Level | $345.63 | $23.62 |
| Average True Range (ATR) | 9.25 | 0.78 |
| MACD | -2.96 | -0.32 |
| Stochastic Oscillator | 4.04 | 6.86 |
Carlisle Companies Inc is a holding company that manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. It operates through two segments: Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The majority of revenue comes from Carlisle Construction Materials, and more than half of total revenue is earned in the United States. Carlisle Construction Materials produces premium single-ply roofing products and warranted roof systems, including EPDM, TPO, PVC membrane, and polyiso insulation. Carlisle Weatherproofing Technologies produces building envelope solutions, including waterproofing, moisture protection products, air/vapor barriers, and spray polyurethane foam systems.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.